....
Press

COVID-19 rapid antigen test notified to BfArM

We are happy to announce that Vakzine Projekt Management GmbH (VPM) together with Grit Overseas Pte. Ltd. in Singapore successfully notified a COVID-19 rapid antigen test to the German Institute for Pharmaceuticals and Medical Products (BfArM).

News

Hope for the elderly in the corona pandemic

First participants receive VPM1002 in a late-stage phase III clinical trial in Germany. Read more!

A competent partner at your side

Free first consulting session

We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.

From Bench to Product

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Next Year

The 13th International VPM Days 2021

On 23 and 24 September 2021, the 13th International VPM Days will take place! Here you can find the report of 2019.

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

More about us

News & Press

COVID

COVIVAXX – a new COVID-19 vaccine under development

COVIVAXX is a new vaccine candidate to protect against COVID-19. Developed by the Serum Institute of India Pvt. LTD (SIIPL), the globally leading vaccine manufacturer, VPM coordinates the clinical development in Europe. A phase I/II trial is currently ongoing in Australia to assess the safety and immunogenicity of COVIVAXX in humans. A pivotal phase III trial is planned to be conducted in Europe and India in the first half of 2021. Click here to read more.

Press

priMe on South African newspaper

The local newspaper in Gauteng, South Africa, reported about the priMe study.
Klick here to read the article.

News

Milestone achieved: Initiation of all clinical centers for a large African trial against tuberculosis in neonates completed

We are pleased to announce that a major milestone in the pivotal phase III trial (trial name: priMe) of the novel tuberculosis vaccine VPM1002 has been achieved with the completed initiation of all clinical trial centers. Read more!

Press

COVID-19 rapid antigen test notified to BfArM

We are happy to announce that Vakzine Projekt Management GmbH (VPM) together with Grit Overseas Pte. Ltd. in Singapore successfully notified a COVID-19 rapid antigen test to the German Institute for Pharmaceuticals and Medical Products (BfArM).

"The DiagnoSure SARS-CoV-2 Antigen Rapid Test is now available and will get reimbursed by the health insurance upon prescription by a doctor.", says Oorvahsk F. Dastoor, Managing Director of Grit Overseas.

The test detects the viral N-protein and is therefore applicable for all virus mutants independent of mutations in their spike protein. This allows a reliable and fast detection of SARS-CoV-2 for everyone.

"We are proud to be involved to make an additional rapid antigen test accessible to the public in this COVID-19 pandemic", says Dr. Leander Grode, Managing Director of VPM. This is the first medicinal product VPM was involved in.

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.
powered by webEdition CMS